Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten]
Observational study · 2010
- What was studied
- 728 analyzable patients with psychoautonomic syndrome in 28 Russian centers
- Main finding
- Reports symptom and quality-of-life improvements during 28 days of Ladasten treatment and follow-up. The abstract reports adverse events in 3% and discontinuation in 0.8%.
CGI-S responders · 76.0%
Reported findings and study design
Uncontrolled multicenter report: 28 centers, 728 analyzed patients (91.6% of the enrolled sample). Ladasten 50–100 mg/day for 28 days; follow-up one month after treatment.
Population or model 728 analyzable patients with psychoautonomic syndrome in 28 Russian centers
Dose, route and schedule
Ladasten (bromantane): 50–100 mg/day for 28 days. The indexed abstract does not specify the route or how the daily dose was divided.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| CGI-S responders | 76.0% | |
| CGI-I responders | 90.8% | |
| First reported antiasthenic effect | Day 3 | |
| Adverse effects | 3% | |
| Stopped therapy | 0.8% | |
| Serious adverse effects | None reported in this cohort |
Responder percentages use different CGI scales. There is no concurrent placebo comparison in the abstract; the results are not independent of duplicate reports of this cohort.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- No concurrent comparator is described in the abstract; improvement alone does not establish causality.
- PMID 21322821 has the same title, cohort and abstract: treat it as a related report of this cohort, not independent replication.
- Short follow-up and incomplete ascertainment cannot rule out uncommon or long-term harms.
Source details
Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.
Sources checked
Citation
Author unconfirmed. Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten] Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 110(5 Suppl 1):17-26. PMID 20559263